Progression of hearing loss following the completion of chemotherapy and radiation therapy: case report.
There have been scattered accounts reported in the oncology literature of progressive hearing loss following the conclusion of chemotherapy. In this case study, we report the audiologic findings of such a case. These data underscore the need for post-therapy monitoring in cases where threshold shifts are discovered during the course of drug administration.
Sweetow
R W
RW
Audiology Clinic, University of California, San Francisco 94143-0340.
Will
T I
TI
D000328:Adult; D001301:Audiometry, Pure-Tone; D001309:Auditory Threshold; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003051:Cochlea / Q000503:physiopathology / Q000528:radiation effects; D015834:Cochlear Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology; D003131:Combined Modality Therapy; D003388:Cranial Fossa, Posterior / Q000473:pathology*; D064420:Drug-Related Side Effects and Adverse Reactions; D004806:Ependymoma / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy; D005260:Female; D006311:Hearing Disorders / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D011878:Radiotherapy / Q000009:adverse effects
D002945:Cisplatin